Newsletter | September 3, 2025

09.03.25 -- Innovating On The Frontier Of Radiopharmaceuticals

SPONSOR

Mark your calendar for BioFuture™ 2025!

BioFuture returns to New York City this October, bringing together pioneers, investors, and decision-makers who are redefining the future of medicine. This year’s summit will focus on the convergence of biopharma, digital medicine, big data, and TechBio. With 600+ attendees, 100+ speakers, and 80+ presenting companies. Learn more and register.

FEATURED PODCAST

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

On this Business of Biotech episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix, talks about his personal journey standing up and growing a radiopharmaceutical company focused on oncology.

INDUSTRY INSIGHTS

Rewriting The Future Of Clinical Trials: AI, Agility, The Portfolio-First Mandate

In an increasingly data-complex environment, eCOA is emerging as a foundational pillar for both operational agility and scientific rigor in clinical development

How Patient Experience Optimization Is Improving Clinical Trial Success

For clinical operations leaders facing tighter budgets and higher expectations, patient experience optimization is essential for building trials that patients can successfully navigate.

Harnessing Predictive Modeling To Overcome Trial Enrollment Challenges

By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures clinical trials meet their enrollment goals more efficiently.

Powering More Efficient Clinical Development With AI And ML

Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.

Can Condition-Based Matching Shift The Trial Recruitment Paradigm?

Condition-based matching is replacing the inefficient, study-by-study model with a patient-centric approach that matches individuals to all relevant trials based on their unique medical profiles.

Everything You Need To Know About Mobile Visits And Community Sites

Discover how decentralized clinical trials (DCTs) and mobile visits contribute to more diverse, efficient, and patient-centric research, ultimately enhancing trial outcomes and data quality.

Inclusive Trial Design A 'Must-Have' In Modern R&D

The call for greater diversity in clinical trials has grown louder. Inclusivity in trial design is crucial for the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health.